Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Koenig

Showing results (311-320 of 312) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 312 results.
Investigational New Drugs|January 6, 2019
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II studyClinton Yam, Francisco J Esteva, Miral M Patel, et al.
ESMO Open|September 3, 2021
PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancersE E Dumbrava, S G Call, H J Huang, et al.
Pageof 32

Showing results (311-320 of 312) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 312 results.
Investigational New Drugs|January 6, 2019
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II studyClinton Yam, Francisco J Esteva, Miral M Patel, et al.
ESMO Open|September 3, 2021
PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancersE E Dumbrava, S G Call, H J Huang, et al.
Pageof 32